Hiroyuki Tanaka

7PUBLICATIONS
3CO-AUTHORS
Epidemiological modellingPredictive and prognostic markersPharmacogenomicsForensic epidemiologyDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 15, 2026
Seasonal Variation in Reporting of Venous Thromboembolism in a Spontaneous Adverse Event Reporting System: Analysis of the Japanese Adverse Drug Event Report Database.

|Apr 30, 2025
Risk Factors for Vancomycin-Induced Nephrotoxicity and Kidney Prognosis in Patients Aged 75 Years and Older: A Retrospective Study.

Masaki Takigawa, Hiroyuki Tanaka, Masako Kinoshita

|Mar 04, 2025
Influence of rapidly increased numbers of reports on adverse events of the COVID-19 vaccine in the Japanese pharmacovigilance database on disproportionality analysis of antineoplastic drug-associated adverse cardiovascular events.

Hajime Matsuo, Hiroyuki Tanaka, Kiri Endo

|Aug 29, 2024
Retrospective Study of Factors Affecting the Accuracy of Predicting Vancomycin Concentrations in Patients Aged 75 Years and Above.

Masaki Takigawa, Hiroyuki Tanaka, Masako Kinoshita

|Apr 28, 2023
Accuracy of Therapeutic Drug Monitoring of Teicoplanin at the Onset of Febrile Neutropenia.

Masaki Takigawa, Hiroyuki Tanaka, Junichi Suwa

|Oct 14, 2022
Understanding the Actual Use of Anti-HIV Drugs in Japan from 2016 to 2019: Demonstrating Epidemiological Relevance of NDB Open Data Japan for Understanding Japanese Medical Care.

Hiroyuki Tanaka, Toshihisa Onoda, Toshihiro Ishii

Pageof 2

Frequent Collaborators

3 joint publications

Masaki Takigawa

1 joint publications

Toshihisa Onoda

1 joint publications

Akihito Ishigami